Sign Up Today

If you have a relative with type 1 diabetes (T1D), you’re in a unique position to help us learn more about the disease and how to stop it. The first step is to sign up for screening through the TrialNet Pathway to Prevention Study.

Take your first step on the Pathway to Prevention!

The Pathway to Prevention Study starts with a simple blood test that can detect your risk of developing T1D years before symptoms appear. Detecting the disease at its earliest stage is super important. If you are in the early stages of T1D, you may be able to join a research study looking for ways to slow down or stop the disease. We invite you to join our TrialNet family and help find a way to prevent T1D.

Sign Up Today!

Pathway to Prevention screening is free to relatives of people with type 1 diabetes. Get started by answering a few simple questions and selecting the screening option that works best for you.

Get Screened!

The first step on the Pathway to Prevention is to sign up for screening.
It’s easy and convenient. Pick the best option for you:

  • Make an appointment at one of 200 TrialNet locations
  • Order a test kit to be mailed directly to you
  • Get screened at a TrialNet community event in your area.

Your Results

Your screening results will be ready in 4 to 6 weeks. They will be made available only to you. If your test results show you are in the early stages of T1D, the next step will be to go to a TrialNet location for follow-up. You may qualify for participation in a prevention study or follow-up monitoring—all offered at no cost to you.

You can make a difference.

Advances in research are made possible because of people just like you. Join the more than 160,000 relatives of people with T1D who have already participated in TrialNet research. With your help, we will continue to learn more about T1D and how to prevent it.

Have questions?

Contact your closest TrialNet Clinical Center with any questions you may have.

Ready to get started?

Click here to sign up for TrialNet Pathway to Prevention type 1 diabetes risk screening.